Cardiotoxicity with doxorubicin, trastuzumab, and development of the metabolic syndrome: Case report. Research, Society and Development, [S. l.], v. 10, n. 5, p. e46910515037, 2021. DOI: 10.33448/rsd-v10i5.15037. Disponível em: https://www.rsdjournal.org/rsd/article/view/15037. Acesso em: 5 dec. 2025.